Mirae Asset Global Etfs Holdings Ltd. Beam Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 156,279 shares of BEAM stock, worth $3.83 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
156,279
Previous 174,180
10.28%
Holding current value
$3.83 Million
Previous $4.08 Million
6.2%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BEAM
# of Institutions
236Shares Held
75.2MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$201 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$192 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$187 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$160 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$118 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.72B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...